Senior Research Biostatistician Manager, Consulting Service
Current Research Interests
Ms. Riedel currently manages the Department's Consulting Service. Through the service, she collaborates with a variety of investigators from Memorial Hospital and SKI.
Ms. Riedel co-chairs the Department's Design and Analysis Workshop. She also serves as Randomization Coordinator of the Biostatistics Service and is responsible for the design and maintenance of the treatment allocation schema for the Center's randomized protocols.
Selected Bibliography
Begg, C.B., E.R. Riedel, P.B. Bach, M.W. Kattan, D. Schrag, J.L. Warren, and P.T. Scardino, Variations in morbidity after radical prostatectomy. N Engl J Med, 2002. 346(15): p. 1138-44.
Shike, M., L. Latkany, E. Riedel, M. Fleisher, A. Schatzkin, E. Lanza, D. Corle, and C.B. Begg, Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. J Clin Oncol, 2002. 20(17): p. 3592-8.
Panageas, K.S., D. Schrag, E. Riedel, P.B. Bach, and C.B. Begg, The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med, 2003. 139(8): p. 658-65.
Hormigo, A., B. Gu, S. Karimi, E. Riedel, K.S. Panageas, M.A. Edgar, M.K. Tanwar, J.S. Rao, M. Fleisher, L.M. DeAngelis, and E.C. Holland, YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res, 2006. 12(19): p. 5698-704.
Goodman, K.A., E. Riedel, V. Serrano, S. Gulati, C.H. Moskowitz, and J. Yahalom, Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma. J Clin Oncol, 2008. 26(32): p. 5240-7.
Iasonos, A., A.S. Wilton, E.R. Riedel, V.E. Seshan, and D.R. Spriggs, A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies. Clin Trials, 2008. 5(5): p. 465-77.
